Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (CrossMab) (CROSSAB-129)

Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

CD64 & malaria antigen

Type

CrossMab

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Target 2

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "CD64 & malaria antigen"

See other bsAb targets related to "CD64"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (CrossMab) (CROSSAB-129). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (CrossMab) (CAT#: CROSSAB-129)

Specifications

Targets

Customer Reviews and Q&As